| Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia E Tissino, D Benedetti, SEM Herman, E Ten Hacken, IE Ahn, KG Chaffee, ... Journal of experimental medicine 215 (2), 681-697, 2018 | 87 | 2018 |
| TIGIT expressing CD4+ T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia K Catakovic, FJ Gassner, C Ratswohl, N Zaborsky, S Rebhandl, ... Oncoimmunology 7 (1), e1371399, 2018 | 80 | 2018 |
| Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors S Ganghammer, J Gutjahr, E Hutterer, PW Krenn, S Pucher, ... Haematologica 101 (3), e99, 2016 | 41 | 2016 |
| CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues X Yu, L Munoz-Sagredo, K Streule, P Muschong, E Bayer, RJ Walter, ... Blood, The Journal of the American Society of Hematology 138 (12), 1067-1080, 2021 | 35 | 2021 |
| Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia JC Gutjahr, E Szenes, L Tschech, D Asslaber, M Schlederer, S Roos, ... Blood, The Journal of the American Society of Hematology 131 (12), 1337-1349, 2018 | 31 | 2018 |
| The role of CD44 in the pathophysiology of chronic lymphocytic leukemia JC Gutjahr, R Greil, TN Hartmann Frontiers in immunology 6, 177, 2015 | 30 | 2015 |
| CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity JC Gutjahr, E Bayer, X Yu, JM Laufer, JP Höpner, S Tesanovic, ... haematologica 106 (8), 2102, 2021 | 29 | 2021 |
| The dimeric form of CXCL12 binds to atypical chemokine receptor 1 JC Gutjahr, KS Crawford, DR Jensen, P Naik, FC Peterson, GPB Samson, ... Science signaling 14 (696), eabc9012, 2021 | 26 | 2021 |
| Expression of ACKR4 demarcates the “peri-marginal sinus,” a specialized vascular compartment of the splenic red pulp K Werth, E Hub, JC Gutjahr, B Bosjnak, X Zheng, A Bubke, S Russo, A Rot, ... Cell reports 36 (2), 2021 | 16 | 2021 |
| Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1 A Rot, JC Gutjahr, A Biswas, M Aslani, E Hub, A Thiriot, UH von Andrian, ... Cell Stem Cell 29 (7), 1013-1015, 2022 | 9 | 2022 |
| TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia E Szenes, A Härzschel, S Decker, E Tissino, J Pischeli, JC Gutjahr, ... Leukemia 34 (9), 2498-2502, 2020 | 5 | 2020 |
| INSIDE‐OUT VLA‐4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB‐TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE E Tissino, D Benedetti, SE Herman, E ten Hacken, IE Ahn, KG Chaffee, ... Hematological Oncology 35, 109-110, 2017 | 1 | 2017 |
| #4574 ATYPICAL CHEMOKINE RECEPTOR 4 IS EXPRESSED IN GLOMERULAR PARIETAL EPITHELIAL CELLS AND MITIGATES THE SEVERITY OF EXPERIMENTAL GLOMERULONEPHRITIS K Artinger, S Russo, J Gutjahr, E Hub, M Samus, AH Kirsch, S Nadkarni, ... Nephrology Dialysis Transplantation 38 (Supplement 1), 2023 | | 2023 |
| Intracellular and nuclear CXCR4 signaling promotes erythroblast enucleation J Gutjahr, E Hub, C Anderson, M Samus, K Artinger, N Dufton, J Burden, ... | | 2023 |
| New unexpected role of CXCL12-CXCR4 signalling in erythropoiesis JC Gutjahr, A Rot EUROPEAN JOURNAL OF IMMUNOLOGY 52, 63-64, 2022 | | 2022 |
| Dimeric CXCL12 (SDF‐1) binds to atypical chemokine receptor 1 (ACKR1/DARC) K Crawford, J Gutjahr, A Rot, B Volkman The FASEB Journal 35, 2021 | | 2021 |
| BCR-Induced VLA-4 Activation in the TCL1 Transgenic Mouse Model for Chronic Lymphocytic Leukemia E Szenes, A Härzschel, E Tissino, P Justine, J Gutjahr, S Pennisi, ... Blood 134, 1730, 2019 | | 2019 |
| CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation JC Gutjahr, E Szenes, L Tschech, M Schlederer, S Roos, D Asslaber, ... iwCLL, 2017 | | 2017 |
| CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation S Roos, M Schlederer, T Hartmann, JC Gutjahr, E Szenes, L Tschech, ... LEUKEMIA & LYMPHOMA 58, 41-42, 2017 | | 2017 |
| UPPLEMENTARY PPENDIX S Ganghammer, J Gutjahr, E Hutterer, PW Krenn, S Pucher, ... | | |
Tanja N. HartmannDepartment of Internal Medicine I, Medical Center University of Freiburg, GermanyVerified email at uniklinik-freiburg.de